GlassScriptPhysician profile
Yvette Jean Decker
NPI 1992387054
$1,913.82
in general payments reported to CMS, 2019-2025
23 companies · $269 in 2025
The $269 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $400 · 2023: $754 · 2024: $491 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,513.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,513.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $385.23 | 2022-2025 | Entrada, General - Pain Management |
| Pfizer INC. | $334.36 | 2023-2025 | |
| Vertos Medical, INC. | $321.43 | 2023-2024 | Mild Device Kit |
| Nalu Medical, INC. | $127.15 | 2023-2025 | Nalu Neurostimulation System |
| Collegium Pharmaceutical, INC. | $86.06 | 2022-2024 | Xtampza, Belbuca |
| Protega Pharmaceutials INC | $75.19 | 2025 | Roxybond |
| Nevro Corp. | $66.63 | 2022 | |
| Scilex Pharmaceuticals INC. | $60.48 | 2022-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $46.48 | 2022-2024 | Relistor |
| Valinor Pharma, LLC | $45.63 | 2023 | Movantik |
| Painteq LLC | $42.48 | 2022-2024 | Painteq |
| Biohaven Pharmaceutical Holding Company LTD. | $41.26 | 2022 | |
| Almatica Pharma LLC | $39.80 | 2022-2023 | Gralise |
| Abbvie INC. | $39.63 | 2022-2024 | |
| Medtronic, INC. | $38.10 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $35.29 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $31.41 | 2023 | Seglentis |
| Stryker Corporation | $21.23 | 2024 | Mild Device Kit |
| Tonix Medicines, INC. | $20.52 | 2025 | Tonmya |
| Bioventus LLC | $18.22 | 2023 | Durolane |
| Azurity Pharmaceuticals, INC. | $14.92 | 2023 | Horizant |
| Arbor Pharmaceuticals, INC. | $13.77 | 2022 | |
| Foundation Fusion Solutions, LLC | $8.55 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yvette Decker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.